A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment with Inhaled AZD7594 in Adolescents (12 to 17 years) with Asthma

Trial Identifier: D3741C00012
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03976869
Start Date: July 2019
Primary Completion Date: July 2020
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Spanish Translation

Trial Locations

Country Location
United States of America, CA Rolling Hills Estates, CA, United States of America, 90274
United States of America, FL Miami, FL, United States of America, 33165
United States of America, FL Miami Lakes, FL, United States of America, 33015
United States of America, Maryland Bethesda, Maryland, United States of America, 20814
United States of America, MO Kansas City, MO, United States of America, 64114
United States of America, OH Columbus, OH, United States of America, 43207
United States of America, OK Oklahoma City, OK, United States of America, 73106
United States of America, TX Boerne, TX, United States of America, 78006
United States of America, TX Dallas, TX, United States of America, 75225
United States of America, UT Murray, UT, United States of America, 84107